In a previous canine OSA exome study, SETD2 was the second most frequently altered gene with a frequency of SNVs of 21% and CNAs of 0% and in a subsequent canine OSA study with WGS 42% of samples had a predicted deleterious mutation in SETD2 [14, 15]. Here, SETD2 is linked to obstructive sleep apnea syndrome.